FCM
MEDP icon

Fourpath Capital Management’s Medpace MEDP Stock Holding History

Fourpath Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-32
Closed -$10.7K – 553
2024
Q3 		$10.7K Buy
+32
New +$12.2K ﹤0.01% 492

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Fourpath Capital Management's MEDP Position: Q4 2024 in Review

Fourpath Capital Management sold out of Medpace (MEDP) in Q4 2024, closing a stake of 32 shares — an estimated $10.7K sold.

Fourpath Capital Management first reported a position in MEDP in Q3 2024 and held it in 1 quarter. The position peaked at $10.7K in Q3 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Fourpath Capital Management reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Fourpath Capital Management sold 32 Medpace shares in Q4 2024, an estimated $10.7K.
  • Fourpath Capital Management first reported a position in Medpace in Q3 2024 and held it in 1 quarter.
  • Fourpath Capital Management's Medpace position peaked at $10.7K in Q3 2024.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Fourpath Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.